Beximco Pharmaceuticals (BXP) Competitors GBX 45.62 -0.88 (-1.89%) As of 09/5/2025 07:37 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock BXP vs. BGSC, GROW, PINE, PRSR, DX, SAGA, ARR, SOHO, MGP, and WPCShould you be buying Beximco Pharmaceuticals stock or one of its competitors? The main competitors of Beximco Pharmaceuticals include BMO Global Smaller Companies (BGSC), Molten Ventures (GROW), Pinewood Technologies Group (PINE), Prs Reit (PRSR), DX (Group) (DX), Saga (SAGA), Aurora Investment Trust (ARR), Triple Point Social Housing REIT (SOHO), Medica Group (MGP), and Witan Pacific Investment Trust PLC (WPC.L) (WPC). These companies are all part of the "trading" industry. Beximco Pharmaceuticals vs. Its Competitors BMO Global Smaller Companies Molten Ventures Pinewood Technologies Group Prs Reit DX (Group) Saga Aurora Investment Trust Triple Point Social Housing REIT Medica Group Witan Pacific Investment Trust PLC (WPC.L) BMO Global Smaller Companies (LON:BGSC) and Beximco Pharmaceuticals (LON:BXP) are both small-cap trading companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends. Does the media favor BGSC or BXP? In the previous week, Beximco Pharmaceuticals had 1 more articles in the media than BMO Global Smaller Companies. MarketBeat recorded 1 mentions for Beximco Pharmaceuticals and 0 mentions for BMO Global Smaller Companies. Beximco Pharmaceuticals' average media sentiment score of 0.59 beat BMO Global Smaller Companies' score of 0.00 indicating that Beximco Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment BMO Global Smaller Companies Neutral Beximco Pharmaceuticals Positive Do insiders & institutionals hold more shares of BGSC or BXP? 1.2% of Beximco Pharmaceuticals shares are held by institutional investors. 4.2% of Beximco Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is BGSC or BXP more profitable? Beximco Pharmaceuticals has a net margin of 13.71% compared to BMO Global Smaller Companies' net margin of 0.00%. Beximco Pharmaceuticals' return on equity of 13.12% beat BMO Global Smaller Companies' return on equity.Company Net Margins Return on Equity Return on Assets BMO Global Smaller CompaniesN/A N/A N/A Beximco Pharmaceuticals 13.71%13.12%6.97% Is BGSC or BXP a better dividend stock? BMO Global Smaller Companies pays an annual dividend of GBX 0.02 per share. Beximco Pharmaceuticals pays an annual dividend of GBX 3.97 per share and has a dividend yield of 8.7%. BMO Global Smaller Companies pays out 0.0% of its earnings in the form of a dividend. Beximco Pharmaceuticals pays out 27.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Which has higher valuation & earnings, BGSC or BXP? Beximco Pharmaceuticals has higher revenue and earnings than BMO Global Smaller Companies. BMO Global Smaller Companies is trading at a lower price-to-earnings ratio than Beximco Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBMO Global Smaller Companies£303.85M0.00N/A£50.70N/ABeximco Pharmaceuticals£46.34B0.00£970.84B£14.253.20 SummaryBeximco Pharmaceuticals beats BMO Global Smaller Companies on 10 of the 12 factors compared between the two stocks. Get Beximco Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BXP vs. The Competition Export to ExcelMetricBeximco PharmaceuticalsDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£203.52M£1.69B£5.77B£2.56BDividend Yield5.63%2.92%6.71%5.31%P/E Ratio3.2066.0675.545,361.39Price / Sales0.001,399.07480.4295,775.36Price / CashN/A10.3736.9627.93Price / Book0.0011.6911.447.02Net Income£970.84B£20.70B£3.28B£5.89B7 Day Performance-2.67%-0.87%0.96%0.62%1 Month Performance1.38%3.72%7.83%56.34%1 Year Performance105.50%4.64%62.64%175.09% Beximco Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BXPBeximco PharmaceuticalsN/AGBX 45.62-1.9%N/A+112.2%£203.52M£46.34B3.205,500News CoverageGap UpBGSCBMO Global Smaller CompaniesN/AN/AN/AN/A£769.56M£303.85M2.77N/AGROWMolten Ventures1.6462 of 5 starsGBX 362+2.5%GBX 580+60.2%-9.3%£645.53M£31.70M-90,500.0020PINEPinewood Technologies Group1.1964 of 5 starsGBX 508+0.4%GBX 590+16.1%+52.4%£581.55M£3.86B814.105,334Positive NewsGap DownPRSRPrs ReitN/AGBX 99.10+0.3%GBX 120+21.1%+2.6%£544.31M£116.05M495.502Positive NewsDXDX (Group)N/AN/AN/AN/A£306.77M£471.20M1,185.0020SAGASagaN/AGBX 199.80+0.9%N/A+91.1%£287.62M£588.30M-170.193,682Trending NewsARRAurora Investment TrustN/AGBX 242-0.4%N/A-3.5%£272.91M-£9.71M-1,799.26N/ASOHOTriple Point Social Housing REITN/AGBX 66.50+0.6%N/A+6.6%£261.66M-£24.90M-718.9210High Trading VolumeMGPMedica GroupN/AN/AN/AN/A£259.85M£76.98M3,516.671,212WPCWitan Pacific Investment Trust PLC (WPC.L)N/AN/AN/AN/A£242.69M£6.74M69.65190 Related Companies and Tools Related Companies BMO Global Smaller Companies Competitors Molten Ventures Competitors Pinewood Technologies Group Competitors Prs Reit Competitors DX (Group) Competitors Saga Competitors Aurora Investment Trust Competitors Triple Point Social Housing REIT Competitors Medica Group Competitors Witan Pacific Investment Trust PLC (WPC.L) Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BXP) was last updated on 9/6/2025 by MarketBeat.com Staff From Our Partners6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWarren Buffett's Strangest AI InvestmentTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredOdd trade could help investors secure their wealth in 2025The most profitable phrase you’ve never heard of... Have you heard of 310F? This simple string of code coul...Eagle Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BXP Stock Alerts